Marksans Pharma Multibagger Target 200 in 2 yrs time frame

Marksans Pharma Multibagger Target 200 Rs in 2 yrs time frame

• Marksans Pharma is onle of the budding Pharmecitcal Commpany in India.The Company Chairman and MD is Mr. Mark Saldanha.The is headquaters in Mumbai.

• The company primarily focus on OTC and prescription drugs which are used in the field of Cardiovascular,Gyno,Diabetics etc.

• Marksan has a Strong Manufacturing facility which is approved by USFDA,MHRA ans TGA.

• The Company has grown in global player using series of Aquastion in various contries. They.They acquired Nova Pharmaceuticals Australasia Pty Ltd in 2005,Relonchem Limited in 2008.

• The company was initially part of Glemark Lab and the got split into 2003 and started its journey as Marksans Pharma Ltd.

• The company operates in lot of Foreign countries Such as US,UK,Australia and Newzeland.They are planning to enter into Russia and CIS markets.With Sales increasing close to 100 Crores from 70 crores (standalone basis), we see it increase to 300 Crores in next 2 years.

• We see this stock starting to comeing under the Radar of Mutual Funds and stock is set to zoom to 400 Rs in 2 year time frame.